Differences in chemokine coreceptor usage between genetic subtypes of HIV-1

Virology

Volumn 241, Issue 2, 1998, Pages 181-188

  Tscherning, Charlotte ^a   Alaeus, Annette ^b   Fredriksson, Robert ^a   Björndal, Åsa ^a   Deng, Hongkui ^c   Littman, Dan R ^c   Fenyö, Eva Maria ^a   Albert, Jan ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE STATUS; LYMPHOCYTE COUNT; LYMPHOID CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRAL GENETICS; VIRUS ISOLATION; VIRUS TRANSMISSION; VIRUS TYPING; VIRUS VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032519399     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8980     Document Type: Article

References (41)

1. Alaeus A., Leitner T., Lidman K., Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS. 11:1997a;199-202.
2. Alaeus A., Lidman K., Sönnerborg A., Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 11:1997b;859-865.
3. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC-CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
4. Åsjö B., Morfeldt-Månson L., Albert J., Biberfeld G., Karlsson A., Lidman K., Fenyö E. M. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. ii:1986;660-662.
5. Björndal Å., Deng H., Jansson M., Fiore J. R., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D. R., Fenyö E. M. Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:1997;7478-7487.
6. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 382:1996;829-833.
7. Boucher C. A. B., Lange J. M. A., Miedema F., Weverling G. J., Koot M., Mulder J. W., Goudsmit J., Kellam P., Larder B., Tersmette M. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS. 6:1992;1259-1264.
8. Morb. Mortal. Wkly Rep. 41:1992;1-19.
9. Cheng-Mayer C., Seto D., Tateno M., Levy J. A. Biological features of HIV-1 that correlate with virulence in the host. Science. 240:1988;80-82.
10. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
11. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science. 270:1995;1811-1815.
12. de Jong J.-J., de Ronde A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J. Virol. 66:1992;6777-6780.
13. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
14. Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusin cofactors. Cell. 85:1996;1149-1158.
15. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-648.
16. Endres M., Clapham P. R., Marsh M., Ahuja M., Davis-Turner J., McKnight A., Thomas J. F., Stoebenau-Haggarty B., Choe S., Vance P. J., Wells T. N. C., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., Hoxie J. A. CD4-independent infection by HIV-2 is mediated by Fusin/CXCR4. Cell. 87:1996;745-756.
17. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor : Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
18. Fenyö E. M. HIV-1 biological phenotype varies with severity of infection across HIV-1 genetic subtypes. Development and Applications of Vaccine and Gene Therapy in AIDS. 1996;Krager, Basel. p. 49-55.
19. Fenyö E. M., Morfeldt-Månson L., Chiodi F., Lind A., von Gegerfelt A., Albert J., Olausson E., Åsjö B. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:1988;4414-4419.
20. Fiore J. R., Björndal Å., Aperia-Peipke K., Di Stefano M., Angarano G., Pastore G., Gaines H., Fenyö E. M., Albert J. The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology. 204:1994;297-303.
21. Fouchier R. A. M., Groenink M., Kootstra N. A., Tersmette M., Huisman H. G., Miedema F., Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:1992;3183-3187.
22. Groenink M., Fouchier R. A. M., de Goede R. E. Y., de Wolf F., Gruters R. A., Cuypers T. M., Huisman H. G., Tersmette M. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J. Virol. 65:1991;1968-1975.
23. Hogervorst E., de Jong J., van Wijk A., Bakker M., Valk M., Nara P., Goudsmit J. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies. J. Virol. 69:1995;6342-6351.
24. Jansson M., Popovic M., Karlsson A., Cocchi F., Albert A., Wigzell H. Sensitivity to inhibition by β-chemokines correlates with biological phenotype of primary HIV-1 isolates. Proc. Natl. Acad. Sci. USA. 93:1996;15382-15387.
25. Karlsson A., Parsmyr K., Sandström E., Fenyö E. M., Albert J. MT-2 cell tropism as a prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32:1994;364-370.
26. +. Ann. Intern. Med. 118:1993;681-688.
27. Koot M., Vos A. H. V., Keet R. P. M., de Goede R. E. Y., Dercksen W., Terpstra F. G., Coutinho R. A., Miedema F., Tersmette M. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS. 6:1992;49-54.
28. Leitner Y., Korovina G., Marquina S., Smolskaya T., Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variants. Aids Res. Hum. Retroviruses. 12:1996;1595-1603.
29. Menu E., Truong T. X., Lafon M. E., Nguyen T. H., Muller-Trutwin M. C., Nguyen T. T., Deslandres A., Chaouat G., Duong Q. T., Ha B. K., Fleury H. J., Barre-Sinoussi F. HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res. Hum. Retroviruses. 12:1996;629-633.
30. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., Morfeldt-Månson L., Åsjö B., Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:1989;901-910.
31. Myers, G. Korber, B. Foley, B. Jeang, K.-T. Mellers, J. W. Wain-Hubson, S. 1996, Human Retroviruses and AIDS 1996: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences, Los Alamos Nat. Lab. Los Alamos, New Mexico.
32. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J. L., Arenzana-Seisdedos F., Schwartz O., Heard J. M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382:1996;833-835.
33. Schuitemaker H., Koot M., Kootstra N. A., Dercksen M. W., de Goede R. E., van Steenwijk R. P., Lange J. M., Schattenkerk J. K., Miedema F., Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus population. J. Virol. 66:1992;1354-1360.
34. Simmons G., Wilkinson D., Reeves J. D., Dittmar M. T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P. W., Weiss R. A., Clapham P. R. Primary, syncytium-inducing Human Immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:1996;8355-8360.
35. Soto-Ramirez L. E., Renjifo B., McLane M. F., Marlik R., O'Hara C., Sutthent R., Wasi C., Vithayasai P., Vithayasai V., Apichartpiyakul C., Auewarakil P., Pena Cruz V., Chui D. S., Osathanondh R., Mayer K., Lee T. H., Essex M. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science. 271:1996;1291-1293.
36. Sundqvist V. A., Albert J., Ohlsson E., Hinkula J., Fenyö E. M., Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol. 29:1989;170-175.
37. Tersmette M., De Goede R. E. Y., Al B. J., Winkel I., Gruters B., Cuypers H. T., Huisman H. G., Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with AIDS and AIDS-related complex. J. Virol. 62:1988;2026-2032.
38. Trkola A., Dragic T., Arthos J., Binley J. M., Olson W. C., Allaway G. P., Cheng-Mayer C., Robinson J., Maddon P. J., Moore J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
39. AIDS Res. Hum. Retroviruses. 10:1994;1327-1343.
40. Wu L., Gerard N. P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A. A., Desjardin E., Newman W., Gerard C., Sodorowski J. CD-4 induced interaction of primary HIV-1 gp120 glycoproteins with chemokine receptor CCR-5. Nature. 384:1996;179-183.
41. Zhang L., Huang Y., He T., Cao Y., Ho D. D. HIV-1 subtype and second-receptor use. Nature. 383:1996;768.